Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly Submits New Type 2 Diabetes Drug for FDA Review
Eli Lilly Submits New Type 2 Diabetes Drug for FDA Review
Eli Lilly Submits New Type 2 Diabetes Drug for FDA Review
Submitted by
admin
on March 26, 2013 - 9:20am
Source:
Motley Fool
News Tags:
diabetes
FDA
Eli Lilly
Boehringer Ingelheim
empagliflozin
Headline:
Eli Lilly Submits New Type 2 Diabetes Drug for FDA Review
Do Not Allow Advertisers to Use My Personal information
